GR79479B - - Google Patents

Info

Publication number
GR79479B
GR79479B GR73259A GR830173259A GR79479B GR 79479 B GR79479 B GR 79479B GR 73259 A GR73259 A GR 73259A GR 830173259 A GR830173259 A GR 830173259A GR 79479 B GR79479 B GR 79479B
Authority
GR
Greece
Application number
GR73259A
Other languages
Greek (el)
Inventor
G Doria
C Passarotti
A Buttinoni
Original Assignee
Erba Farmitalia
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB838329746A external-priority patent/GB8329746D0/en
Application filed by Erba Farmitalia filed Critical Erba Farmitalia
Publication of GR79479B publication Critical patent/GR79479B/el

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D285/00Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/01Five-membered rings
    • C07D285/02Thiadiazoles; Hydrogenated thiadiazoles
    • C07D285/04Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
    • C07D285/121,3,4-Thiadiazoles; Hydrogenated 1,3,4-thiadiazoles
    • C07D285/1251,3,4-Thiadiazoles; Hydrogenated 1,3,4-thiadiazoles with oxygen, sulfur or nitrogen atoms, directly attached to ring carbon atoms, the nitrogen atoms not forming part of a nitro radical
    • C07D285/135Nitrogen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D513/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pain & Pain Management (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Rheumatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GR73259A 1982-12-23 1983-12-15 GR79479B (cg-RX-API-DMAC7.html)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB8236642 1982-12-23
GB838329746A GB8329746D0 (en) 1983-11-08 1983-11-08 Carboxamido-derivatives

Publications (1)

Publication Number Publication Date
GR79479B true GR79479B (cg-RX-API-DMAC7.html) 1984-10-30

Family

ID=26284768

Family Applications (1)

Application Number Title Priority Date Filing Date
GR73259A GR79479B (cg-RX-API-DMAC7.html) 1982-12-23 1983-12-15

Country Status (15)

Country Link
US (1) US4522944A (cg-RX-API-DMAC7.html)
AT (1) AT385036B (cg-RX-API-DMAC7.html)
AU (1) AU558600B2 (cg-RX-API-DMAC7.html)
CA (1) CA1211440A (cg-RX-API-DMAC7.html)
CH (1) CH657136A5 (cg-RX-API-DMAC7.html)
DE (1) DE3346223A1 (cg-RX-API-DMAC7.html)
DK (1) DK593983A (cg-RX-API-DMAC7.html)
FI (1) FI834698A7 (cg-RX-API-DMAC7.html)
FR (1) FR2538392B1 (cg-RX-API-DMAC7.html)
GR (1) GR79479B (cg-RX-API-DMAC7.html)
IL (1) IL70522A (cg-RX-API-DMAC7.html)
IT (1) IT1194521B (cg-RX-API-DMAC7.html)
NL (1) NL8304340A (cg-RX-API-DMAC7.html)
SE (1) SE454698B (cg-RX-API-DMAC7.html)
SU (1) SU1297731A3 (cg-RX-API-DMAC7.html)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3702758A1 (de) * 1987-01-30 1988-09-29 Hoechst Ag Substituierte 3-phenyl-7h-thiazolo (3,2-b) (1,2,4) triazin-7-one, verfahren zu ihrer herstellung, die sie enthaltenden arzneimittel und ihre verwendung, sowie einige bei der herstellung der genannten verbindungen gebildete zwischenprodukte
CA2679754C (en) 2007-03-12 2018-08-07 Intra-Cellular Therapies, Inc. Substituted heterocycle fused gamma-carbolines synthesis
US9428506B2 (en) 2012-04-14 2016-08-30 Intra-Cellular Therapies, Inc. Substituted pyrido[3′,4′:4,5]pyrrolo[1,2,3-de]quinoxalines for the treatment of nervous system disorders
EP2968320B1 (en) 2013-03-15 2020-11-11 Intra-Cellular Therapies, Inc. Organic compounds
DK3076967T3 (da) 2013-12-03 2021-10-25 Intra Cellular Therapies Inc Fremgangsmåder til behandling af residuelle symptomer på skizofreni
MX2016013046A (es) 2014-04-04 2017-02-15 Intra Cellular Therapies Inc Compuestos organicos.
CN106535898A (zh) 2014-04-04 2017-03-22 细胞内治疗公司 有机化合物
PL3838274T3 (pl) 2016-01-26 2024-04-02 Intra-Cellular Therapies, Inc. Pochodna pirydo[3',4':4,5]pirolo[1,2,3-DE]chinoksaliny do zastosowania w leczeniu zaburzeń OUN
WO2017172784A1 (en) 2016-03-28 2017-10-05 Intra-Cellular Therapies, Inc. Novel salts and crystals
JP2019510039A (ja) 2016-03-28 2019-04-11 イントラ−セルラー・セラピーズ・インコーポレイテッドIntra−Cellular Therapies, Inc. 新規組成物および方法
US11014925B2 (en) 2016-03-28 2021-05-25 Intra-Cellular Therapies, Inc. Co-crystals of 1-(4-fluoro-phenyl)-4-((6bR,1OaS)-3-methyl-2,3,6b,9,10,10a-hexahydro-1H,7H- pyrido[3′,4′:4,51_pyrrolo [1,2,3-delqcuinoxalin-8-yl)-butan-1-one with nicotinamide or isonicotinamide
US11331316B2 (en) 2016-10-12 2022-05-17 Intra-Cellular Therapies, Inc. Amorphous solid dispersions
EP3562484B1 (en) 2016-12-29 2021-08-25 Intra-Cellular Therapies, Inc. Pyrido[3',4':4,5]pyrrolo[1,2,3-de]quinoxaline derivatives useful in the treatment of cns disorders
US10961245B2 (en) 2016-12-29 2021-03-30 Intra-Cellular Therapies, Inc. Substituted heterocycle fused gamma-carbolines for treatment of central nervous system disorders
RU2767410C2 (ru) 2017-03-24 2022-03-17 Интра-Селлулар Терапиз, Инк. Новые композиции и способы
KR102667268B1 (ko) 2017-07-26 2024-05-17 인트라-셀룰라 써래피스, 인코퍼레이티드. 유기 화합물
EP3658145A4 (en) 2017-07-26 2021-04-21 Intra-Cellular Therapies, Inc. ORGANIC COMPOUNDS
CN112040940A (zh) 2018-03-23 2020-12-04 细胞内治疗公司 有机化合物
CN112384218B (zh) 2018-06-06 2024-04-26 细胞内治疗公司 盐和晶体
ES3028377T3 (en) 2018-06-08 2025-06-19 Intra Cellular Therapies Inc Fused gamma-carbolines for acute treatment of anxiety or depression
KR20250034203A (ko) 2018-06-11 2025-03-10 인트라-셀룰라 써래피스, 인코퍼레이티드. 치환된 헤테로환 융합 감마-카르볼린 합성
JP2022500362A (ja) 2018-08-29 2022-01-04 イントラ−セルラー・セラピーズ・インコーポレイテッドIntra−Cellular Therapies, Inc. 新規組成物および方法
AU2019331490B2 (en) 2018-08-31 2025-04-24 Intra-Cellular Therapies, Inc. Novel methods
CA3108553A1 (en) 2018-08-31 2020-03-05 Intra-Cellular Therapies, Inc. Novel methods
EP4134101A1 (en) 2019-07-07 2023-02-15 Intra-Cellular Therapies, Inc. Deuterated lumateperone for the treatment of the bipolar ii disorder
JP7261942B2 (ja) 2019-12-11 2023-04-20 イントラ-セルラー・セラピーズ・インコーポレイテッド 有機化合物
US12414948B2 (en) 2022-05-18 2025-09-16 Intra-Cellular Therapies, Inc. Methods

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5129981B2 (cg-RX-API-DMAC7.html) * 1973-07-17 1976-08-28
GB1568962A (en) * 1975-10-31 1980-06-11 Beecham Group Ltd Reparation and compositions containing them (heterocyclic-carbonylamino)pencillins methods for their p
JPS55115889A (en) * 1979-02-28 1980-09-06 Teijin Ltd 6-carbamoylthiazolo 3,2-a pyrimidine derivative and its preparation
JPS57142989A (en) * 1981-02-27 1982-09-03 Dai Ichi Seiyaku Co Ltd Thiazolopyrimidine derivative

Also Published As

Publication number Publication date
FR2538392A1 (fr) 1984-06-29
IT1194521B (it) 1988-09-22
AT385036B (de) 1988-02-10
FI834698A0 (fi) 1983-12-20
SU1297731A3 (ru) 1987-03-15
IT8324207A0 (it) 1983-12-16
AU2252583A (en) 1984-06-28
FR2538392B1 (fr) 1987-01-16
AU558600B2 (en) 1987-02-05
DK593983D0 (da) 1983-12-22
US4522944A (en) 1985-06-11
FI834698A7 (fi) 1984-06-24
DK593983A (da) 1984-06-24
CH657136A5 (de) 1986-08-15
ATA438383A (de) 1987-07-15
IL70522A (en) 1986-02-28
CA1211440A (en) 1986-09-16
SE454698B (sv) 1988-05-24
DE3346223A1 (de) 1984-06-28
SE8307133L (sv) 1984-06-24
NL8304340A (nl) 1984-07-16
IL70522A0 (en) 1984-03-30
SE8307133D0 (sv) 1983-12-22

Similar Documents

Publication Publication Date Title
CH650894GA3 (cg-RX-API-DMAC7.html)
CH655392B (cg-RX-API-DMAC7.html)
FR2519822B1 (cg-RX-API-DMAC7.html)
FR2519958B1 (cg-RX-API-DMAC7.html)
GR78786B (cg-RX-API-DMAC7.html)
GR79479B (cg-RX-API-DMAC7.html)
DE3375853T2 (cg-RX-API-DMAC7.html)
FR2520114B1 (cg-RX-API-DMAC7.html)
FR2520279B1 (cg-RX-API-DMAC7.html)
FR2520123B1 (cg-RX-API-DMAC7.html)
FR2519812B2 (cg-RX-API-DMAC7.html)
FR2519809B1 (cg-RX-API-DMAC7.html)
CH655536B (cg-RX-API-DMAC7.html)
FR2519673B1 (cg-RX-API-DMAC7.html)
FR2519745B3 (cg-RX-API-DMAC7.html)
FR2520063B3 (cg-RX-API-DMAC7.html)
FR2519914B3 (cg-RX-API-DMAC7.html)
FR2520423B1 (cg-RX-API-DMAC7.html)
FR2520019B1 (cg-RX-API-DMAC7.html)
FR2519849B1 (cg-RX-API-DMAC7.html)
FR2520267B1 (cg-RX-API-DMAC7.html)
FR2519715B1 (cg-RX-API-DMAC7.html)
FR2519448B1 (cg-RX-API-DMAC7.html)
FR2519964B1 (cg-RX-API-DMAC7.html)
FR2519872B3 (cg-RX-API-DMAC7.html)